LUCA Science is at the forefront of a new kind of mitochondrial therapy that aims to restore cellular bioenergetics in malfunctioning or damaged tissues and organs. Using our patented iMIT technology, LUCA Science is creating a novel platform of highly functional mitochondria. We could boost bioenergetics and restore normal activities by supplyingintact and functional mitochondria to the affected tissues. The utilization of mitochondria as a biopharmaceutical agent would be groundbreaking for treating a wide range of unmet medical needs.

Biotechnology

Health Care

Pharmaceutical

LUCA Science Inc.

LUCA Science Inc.'s headquarters in Tokyo, Japan

Description

People (2)

Jobs (0)

Other offices